In the last years, several preclinical studies and clinical trials have been effectuated using different GSK-3 inhibitors, actually with few encouraging results
Potential Clinical Applications of GHK-Cu Peptide France Laboratory studies have found that GHK-Cu that GHK-Cu can have the following clinical applications: Enhances Collagen Synthesis According to studies, GHK-Cu activates fibroblasts, the skin cells that produce collagen, which greatly increases collagen production and provides anti-aging advantages
At 8-12 weeks is when the long-term cognitive and mood-stabilizing effects take hold, along with the less outwardly expressed benefits of the peptide (i.e., reduced inflammation, improved immune function, and neuroprotection)
, BPC-157 ,
Preclinical evidence in rabbits showed that BPC-157 significantly accelerated healing of segmental bone defects, with callus formation twice the size of controls and complete bony bridging achieved within six weeks